Neuro Event Labs Raises €2M to Revolutionize Epilepsy Monitoring and Patient Care

Neuro Event Labs Oy is thrilled to announce the successful completion of a funding round that raised 2,000,000, marking a significant milestone in our journey to transform epilepsy care. Founded in 2015 as a spin-off of Intopalo, our company has remained steadfast in our mission to develop scalable solutions designed to revolutionize how patient data, specifically epilepsy seizure data, is captured and analyzed. Our breakthrough technology harnesses advanced video recording techniques along with data from other innovative sensors to monitor seizure events with unprecedented precision. This state-of-the-art approach is further enhanced by intelligent analytics that enable medical professionals to sift through and interpret vast amounts of data quickly and accurately, thereby facilitating more informed decision-making in clinical settings. In addition, our suite of patient-centric tools is engineered to empower individuals, encouraging them to take a proactive role in managing their own health and care routines. With this fresh influx of capital, Neuro Event Labs Oy plans to accelerate development of our technology platform, expand our research capabilities, and increase our collaborative efforts with leading medical institutions. The funds will also be allocated towards further refining our sensor integration systems and developing additional features that improve the accuracy and usability of our analytics. By leveraging this investment, we are poised to push the boundaries of medical monitoring solutions and set new standards in epilepsy care. This funding milestone not only underscores the confidence our investors have in our vision but also ignites renewed commitment within our team to enhance patient outcomes and deliver innovative healthcare solutions across the board.